overview
biotechnology
medical devices
healthcare services
recent investments


CompanyDescriptionStatus Stage / Year
BIKAM Pharmaceuticals, Inc. Novel small molecule therapeutics for ophthalmic diseases Private Start-up / 2007*

Novel drug delivery devices for the respiratory drug market Private Early / 2007*

iVital, Inc.

Develops weight loss surgery clinics Private Seed / 2007*

Develops novel molecular diagnostics with broad applications in infectious disease Private Start-up / 2007*
Developing modified form of heparin to ameliorate cardiac ischemia-reperfusion injury following myocardial infarction. Private Start-up / 2006*
Medical malpractice insurance carrier focused on select markets with tort reform Private Start-up / 2006*
Novel antibiotics using patented bacterial RNA targets to treat pathogens resistant to existing drugs Private Seed / 2006*

Specialty pharmaceuticals for dermatology based on proprietary drug delivery technologies Private Early / 2006*
Novel anti-inflammatory agents based on endogenous mediators of inflammation resolution Private Seed / 2005*

Non-invasive monitor to measure blood glucose from the conjunctiva of the eye Private Start-up / 2005*


Millennium Pharmacy Systems, Inc.

Institutional pharmacy serving skilled nursing facilities Private Early / 2005*
Provides services to acute psychiatric patients Private Seed / 2004*
Medicare Advantage healthcare provider for frail and elderly nursing facility patients Private Seed / 2004*
Therapeutics that target hypoxic cells to treat cancer and benign prostatic hyperplasia IPO 2005 Early / 2003
Devices to treat varicose veins by sclerosing the saphenous vein Private Early / 2003*
Devices that treat Alzheimer's disease by draining stagnant cerebrospinal fluid from the brain Private Later / 2003*
Catheter-based devices to treat occluded arteries Acquired by Johnson & Johnson, 2005 Later / 2002*
Developer of chip-based instruments and reagents for molecular diagnostics Acquired by Becton Dickinson, 2006 Early / 2002*
Developer of advanced materials, techniques and implant systems for spine surgeryPrivate Start-up / 2002
Utilizes engineered bioassays to identify new drug candidates which regulate gene expression Private Start-up / 2002*
Small molecule therapeutics for genetic disorders IPO 2007 Seed / 2002*
Outpatient clinics providing primary care for veterans and indigent patients Private Early / 2002*
Vaccine development Private Seed / 2002*
Development and manufacture of protein microarrays Acquired by Invitrogen Corporation, 2004 Seed / 2001*
Consumer focused applied genomics IPO 2005 Start-up / 2000
Specialized imaging and drug delivery Private Early / 2000*
Site management organization for clinical trials of neuropsychiatric drugs Private Start-up / 1999*
Long-term acute care facilities Acquired by Select Medical Corporation, 2005 Start-up / 1999*
Cellular and proteomics approaches to target validation for drug development Private Seed / 1998*
Novel technologies for immunodiagnostics Acquired by QIAGEN N.V., 2004 Start-up / 1998*

(formerly Emergency Medical Systems)		Devices to assist in the resuscitation of victims of sudden cardiac arrest Acquired by Zoll Medical Corporation, 2004 Early / 1998*

* Board representation at time of investment





 © 2007 CHL Medical Partners. All rights reserved.